Cardinal Health Reports Q3 FY2026 Results and Raises EPS Guidance
Cardinal Health reported a 11% increase in Q3 FY2026 revenue to $60.9 billion, but GAAP operating earnings fell 30% to $509 million due to a goodwill impairment. Non-GAAP metrics showed growth, with non-GAAP diluted EPS rising 35% to $3.17, and the company raised its FY2026 non-GAAP EPS guidance to $10.70 to $10.80.
Tickers: $CAH
Topics: debt reduction earnings EPS guidance revenue share repurchase